| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T39 |
0-11 |
Sentence |
denotes |
Question 2. |
| T40 |
12-52 |
Sentence |
denotes |
Should antiviral agents be administered? |
| T41 |
53-183 |
Sentence |
denotes |
At the present time, evidence from the first published RCT does not support off-label treatment with LPV/RTV in COVID-19 patients. |
| T42 |
184-328 |
Sentence |
denotes |
This result should also discourage the use of other protease inhibitors (e.g. darunavir), at least until results of dedicated RCT are available. |
| T43 |
329-551 |
Sentence |
denotes |
Although promising in preclinical studies, remdesivir should be currently provided to COVID-19 patients only within RCT (preferentially) or compassionate-use/expanded-access programmes, owing to its investigational nature. |
| T44 |
552-736 |
Sentence |
denotes |
Pending high-level supporting evidence, favipiravir and umifenovir should not be provided an outside RCT, at least in those countries where they are not approved for other indications. |
| T45 |
737-844 |
Sentence |
denotes |
Oseltamivir or zanamivir should be provided only in the presence of suspected/proven concomitant influenza. |
